Bibliographic Details
| Title: |
TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial) |
| Authors: |
Ioka, Tatsuya, Ueno, Makoto, Ueno, Hideki, Park, Joon Oh, Chang, Heung-Moon, Sasahira, Naoki, Kanai, Masashi, Chung, Ik Joo, Ikeda, Masafumi, Nakamori, Shoji, Mizuno, Nobumasa, Omuro, Yasushi, Yamaguchi, Taketo, Hara, Hiroki, Sugimori, Kazuya, Furuse, Junji, Maguchi, Hiroyuki, Furukawa, Masayuki, Fukuzawa, Kengo, Kim, Jun-Suk, Yukisawa, Seigo, Takeuchi, Masahiro, Okusaka, Takuji, Boku, Narikazu, Hyodo, Ichinosuke |
| Source: |
In European Journal of Cancer January 2019 106:78-88 |
| Database: |
ScienceDirect |
